Amanda McDowell

What is triple-negative breast cancer?

While breast cancer is often thought of as a singular diagnosis, it is actually an umbrella term that encompasses several subtypes of the disease — many of which have been discovered in recent years due to continual advancement in the oncology research space. Traditionally, breast cancers are grouped into subtypes according to the Tumor, Nodes, and Metastasis system of staging breast cancer, the ...

Continue reading

How to advertise clinical trials online

When sponsors advertise a clinical trial online, they will typically either provide sites with individual advertising budgets or work with a clinical trial recruitment company to create outreach materials. Once created, these materials will undergo the IRB approval process and then be distributed across online channels such as Facebook and Google Ads.

Continue reading

A closer look at resistant hypertension for American Heart Month

Did you know that February is American Heart Month? This month is dedicated to raising awareness for and providing education on heart health, high blood pressure, and cardiovascular disease.

Continue reading

Trends in the medical research space: Reflections from SCOPE 2023

The Summit for Clinical Ops Executives (known as SCOPE), is one of the year’s largest conferences focused on clinical research — and one the Antidote team was thrilled to attend in 2023.

Continue reading

How long do clinical trial phases take?

Before any new medication, treatment, or therapy can be administered to patients, it must progress through the proper clinical trial phases, which are designed to test the drug or device in question for safety and effectiveness. This process can take a long time — in most cases, an average of 10 years will pass between initial discovery to full approval, with the clinical trial stages taking six ...

Continue reading

Antidote's curated journey capabilities [one-pager]

When matching individuals to medical research opportunities, patient centricity is at the heart of the process for Antidote. Through our best-in-class clinical trial matching software, we provide a streamlined, user-friendly experience for any individual searching for a trial — and now, through our curated journeys, we’re able to refine this process even more.

Continue reading

How Antidote uses database insights to drive lupus research [whitepaper]

Lupus is a chronic autoimmune disease that causes the body to attack its own tissues and organs. For the 1.5 million people in the United States that live with the disease, it has severe implications — symptoms include pain, fatigue, hair loss, cognitive issues, physical impairments, and disfiguring rashes. An estimated 10-15% of lupus patients will die prematurely due to the condition.

Continue reading

COPD resources: Where to find the information and support you need

Chronic obstructive pulmonary disease, known commonly as COPD, is a condition that impacts more than 16 million Americans. COPD is a chronic, inflammatory lung disease that obstructs the airflow to and from the lungs, and common symptoms include a continual cough, shortness of breath, excess mucus, and chest tightness.For those living with COPD, their loved ones, and their care partners, we’re ...

Continue reading

Antidote Technologies and XpertPatient partner to empower newly-diagnosed cancer patients to take part in clinical research

We’re excited to share that today, we announced a partnership with XpertPatient, an award-winning educational website that provides support to newly-diagnosed cancer patients. We are providing the XpertPatient community with access to Antidote Match™, our patient-friendly clinical trial search that currently powers clinical trial matching for 300+ patient organizations.

Continue reading

7 clinical trial patient recruitment and retention tips

Clinical trial patient recruitment is a major challenge in the industry — 85% of trials fail to recruit enough patients, 80% are delayed due to recruitment problems, and dropout rates soar. Both at the recruitment and retention stages, taking a patient-centric approach to clinical trial design is a must in order to set your trial up for success.

Continue reading

Get our latest posts in your inbox